Monoclonal antibody targeting human Claudin18.2 protein and application thereof
A monoclonal antibody, targeting technology, applied in the field of biological cells, can solve problems such as frequent ectopic activation
Active Publication Date: 2022-07-15
SHENZHEN FIRST CONDOR BIOSCIENCE CO LTD
View PDF4 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
The expression distributions of Claudin 18.1 and Claudin 18.2 are different, Claudin18.1 is selectively expressed in normal lung cells, and Claudin 18.2 is highly restricted in normal cells, but in a variety of tumors (such as gastric cancer, lung cancer and pancreatic cancer frequent ectopic activation and overexpression in
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0120] The preparation method and functional verification of the antibody of the present embodiment include the following steps:
[0121] S100: Mouse immunization and sequence acquisition of mouse monoclonal antibody
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to the technical field of biological antibodies, in particular to a monoclonal antibody targeting human Claudin18.2 protein and application of the monoclonal antibody. The monoclonal antibody comprises a heavy chain variable region HV and a light chain variable region LV, and the amino acid sequence and the nucleic acid sequence of the monoclonal antibody can be used in a single-chain manner or in a double-chain combined manner. The monoclonal antibody can specifically recognize the human Claudin18.2 antigen, does not recognize the human Claudin18.1 antigen, has good specificity in normal human tissues, is only combined with Claudin18.2 positive tissues, does not recognize other tissues and organs, and has no miss-target risk. The monoclonal antibody has a specific antibody mediated complement dependent (CDC) killing effect on Claudin18.2 positive target cells, and the CAR-T prepared from the monoclonal antibody has a specific killing function on the Claudin18.2 positive target cells.
Description
[0001] This application is a divisional application with an application number of 202111031017X, an application date of September 3, 2021, and the application name is a monoclonal antibody targeting human Claudin18.2 protein and its application. technical field [0002] The invention relates to the technical field of biological cells, in particular to a monoclonal antibody targeting human Claudin18.2 protein, which can be used as a biological material for the construction of other DNA vectors, recombinant protein expression, cell line construction and chimeric antigen receptors In immune cells; or after coupling with other substances, it can be used as a biological agent, or it can be used directly as a biological agent. Background technique [0003] Claudins, a family of proteins that maintain tight junctions that control molecular exchange between cells, are widely distributed in stomach, pancreas, and lung tissues and can be used for disease diagnosis and treatment. The C...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C07K16/30C12N15/13G01N33/577G01N33/574G01N33/68C07K19/00C12N15/867C12N5/10
CPCC07K16/28C07K16/3046C07K16/3023C07K16/303C07K16/30G01N33/577G01N33/57446G01N33/57438G01N33/57423G01N33/57407G01N33/57492G01N33/68C07K14/7051C12N15/86C12N5/0636C07K2317/56C07K2317/565C07K2317/734C07K2317/92C07K2317/33C07K2317/622G01N2333/705C07K2319/02C07K2319/03C07K2319/33C12N2740/15043C12N2800/107C12N2510/00Y02A50/30
Inventor 谢海涛都晓龙马丽雅
Owner SHENZHEN FIRST CONDOR BIOSCIENCE CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com